Rajalakshmi Sabanayagam
Coimbatore, TN 641021, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Inhibitory Effects of Hesperetin and EGCG in the Lung Cancer Progression involves impairment in TOP2A gene expression regulation.
Journal: Applied biochemistry and biotechnology
Published: September 23, 2025
EGF induces SOD activity, TNF-α/IL-6 expression and complement regulatory proteins in cervical cancer cells: suppression by EGCG.
Journal: Medical oncology (Northwood, London, England)
Published: August 07, 2025
EGCG remodels the TGF-β cervical cancer micro-environment towards immune responsiveness.
Journal: Cellular immunology
Published: July 19, 2025
Plumbagin as a preferential lead molecule to combat EGFR-driven matrix abundance and migration of cervical carcinoma cells.
Journal: Medical oncology (Northwood, London, England)
Published: December 07, 2023
A comparative analysis of phyto-components on EGFR binding, viability, and migration in HPV positive ME180 and HPV negative C33A cervical cancer cells.
Journal: Medical oncology (Northwood, London, England)
Published: September 06, 2023
EGCG attenuate EGF triggered matrix abundance and migration in HPV positive and HPV negative cervical cancer cells.
Journal: Medical oncology (Northwood, London, England)
Published: June 20, 2023
Pharmacophore based virtual screening for identification of effective inhibitors to combat HPV 16 E6 driven cervical cancer.
Journal: European journal of pharmacology
Published: February 07, 2023
A review on the role of epidermal growth factor signaling in the development, progression and treatment of cervical cancer.
Journal: International journal of biological macromolecules
Published: September 14, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026